Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.

ABSTRACT:

Importance

Kawasaki disease (KD) symptoms significantly overlap with multisystem inflammatory syndrome in children due to COVID-19. Patients with KD may be at risk for adverse outcomes from exposure to SARS-CoV-2 infection or vaccination.

Objective

To describe the outcomes of patients with KD to SARS-CoV-2 infection or vaccination.

Design, setting, and participants

This case series evaluated 2 cohorts using an existing KD database and reviewed individual electronic medical records for the period spanning January 1, 2020, through January 31, 2022, via electronic medical records that include Washington state immunization records. Vaccine cohort inclusion criteria consisted of being 21 years or younger at immunization and receiving 1 or more BNT162b2 (Pfizer-BioNTech) or

SUBMITTER: Beckley M 

PROVIDER: S-EPMC9375169 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature